Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03956680 |
| Title | An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Bristol-Myers Squibb |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Local Institution - 0003 | Chicago | Illinois | 60637 | United States | Details | |
| Local Institution - 0005 | Saint Louis | Missouri | 63110 | United States | Details | |
| Local Institution - 0006 | Pittsburgh | Pennsylvania | 15232-1305 | United States | Details | |
| Local Institution - 0002 | Nashville | Tennessee | 37232 | United States | Details | |
| Local Institution - 0001 | Toronto | Ontario | M5G 1Z5 | Canada | Details |